BIOPORTO DIAGNOSTICS A/S
BioPorto develops diagnostic tools for early kidney injury detection.
Oversigt
- 24
- Medarbejdere
- Ukendt
- Omsætning
- 1995
- Grundlagt
Beskrivelse
BioPorto is an in vitro diagnostics company dedicated to improving patient outcomes through the development of actionable biomarkers. The company specializes in the NGAL biomarker, which is used to aid in the risk assessment and diagnosis of Acute Kidney Injury (AKI). By leveraging expertise in anti...